A first-in-human study to learn about how safe the study drug is in healthy participants
22819
Phase 1 other active
Quick answer
A first-in-human study to learn about how safe the study drug is in healthy participants for Cardiac arrhythmia is a Phase 1 program (other) at Bayer AG with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Bayer AG
- Indication
- Cardiac arrhythmia
- Phase
- Phase 1
- Modality
- other
- Status
- active